Doravirine

Category: HIV / AIDS

Doravirine Overview

Doravirine, sold under the brand name Pifeltro, is a non-nucleoside reverse transcriptase inhibitor medication developed by Merck & Co. for use in the treatment of HIV/AIDS. Doravirine was approved for medical use in the United States in August 2018.[5] References ^ a b .mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-g...

Read more Doravirine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Doravirine

Recent Doravirine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Doravirine or a similar ingredient: (3 results)

• PIFELTRO Doravirine
• DELSTRIGO Doravirine + Lamivudine + Tenofovir Disoproxil Fumarate
• DORAVIRINE + LAMIVUDINE + TENOFOVIR DISOPROXIL FUMARATE